Tumor burden before and after response to BL22. Matched sCD22 levels before (PRE) and after achieving PR (A) or CR (B) in patients with HCL. HCL cell concentrations were determined by flow cytometry before (PRE) and after achieving PR (C) and CR (D) to BL22.